The US Pharmacopeial Convention’s new plan will include new and revised quality standards and activities to support the development of new generic drugs.

In a deal potentially worth up to $460 million, Genentech and Xencor will develop and commercialize novel cytokine therapeutics.

A solid lipid excipient from ABITEC is designed for multiple dosing forms.

A new reactor flask heating system now offered by Asynt allows the conduction of safe experiments in academic teaching and research labs.

Keeping abreast of the latest industry trends and retaining flexibility are key to maintaining a strong market position.

New HHS proposal would remove the current safe harbor protection from the federal Anti-Kickback Statute for rebates or discounts provided to Medicare Part D drug plans and certain state Medicaid programs.

Company launches new services dedicated to emerging biotech and biopharma companies.

As we approach the next instalment of Pharmapack Europe, a potentially perilous situation in relation to drug packaging has emerged for pharmaceutical companies should Brexit result in a ‘no deal’ scenario.

Biosimilars, pricing strategies, and technology will influence growth in spending on drugs.

Various groups and stakeholders from pharma, healthcare, and government are responding to a new draft environmental risk assessment guidance from EMA.

A new initiative has been launched to help stimulate industry discussion on innovative tech for use across the drug supply chain.

Pharmapack Europe event organizers have released a report titled, ‘European drug delivery and packaging’ that forecasts an increase in innovation from smaller European companies.

The ABPI has released a statement calling for action to address skills shortages in science within the UK, which could jeopardize the country’s position for medicines and vaccines R&D.

Validair Monitoring Solutions has secured new funding that will be used to support the growth of the company across the UK.

ChargePont Technology has revealed that it is now able to expand its smart monitoring technology into North America thanks to being granted HazLoc (Hazardous Area) certification.

A Memorandum of Understanding (MoU) has been signed by the UK’s MHRA and the State Institute of Drugs and Good Practices of the Ministry of Industry and Trade of the Russian Federation.

TrakCel and WindMIL Therapeutics have formed a partnership to build a custom-configured cellular supply chain tracking and orchestration platform.

Sphere Fluidics has closed its latest investment round in which it raised US$2 million (approximately £1.5 million).

The acquisition will boost Hitachi Chemical’s presence in the European regenerative medicines market.

Janssen and MeiraGTx will collaborate on the development and commercialization of gene therapies for treating inherited retinal diseases.

Formulatrix’s FLO i8 and Flow Axial Seal Tip liquid handlers offer automated transferring.

The company is recalling three additional lots of Ibuprofen Oral Suspension Drops, USP, 50 mg per 1.25 mL because of a higher concentration of ibuprofen.

In a statement, FDA Commissioner Scott Gottlieb announced the agency’s plans to publish guidance to promote the development of complex generic drugs.

Danapak Flexibles, a subsidiary of the Schur Flexibles Group, will be showcasing its flexible packaging solutions during Pharmapack Europe in Paris, 6–7 February 2019.

Visitors to Schubert-Pharma’s stand at Pharmapack Europe will learn about the company’s range of packaging solutions and engineering services for the pharma and healthcare industries.

FDA staffers will be hard-pressed to process and review the wave of new drug application submissions in pre-established timeframes for action.

SGS announces expansion of cell bank and bulk harvest testing services.

CDMO leader Marc Funk will succeed Ridinger as CEO of Lonza.